Adibi v. California State Board of Pharmacy

393 F. Supp. 2d 999, 2005 U.S. Dist. LEXIS 23657, 2005 WL 2491567
CourtDistrict Court, N.D. California
DecidedOctober 7, 2005
DocketC-05-0605 EMC
StatusPublished
Cited by3 cases

This text of 393 F. Supp. 2d 999 (Adibi v. California State Board of Pharmacy) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Adibi v. California State Board of Pharmacy, 393 F. Supp. 2d 999, 2005 U.S. Dist. LEXIS 23657, 2005 WL 2491567 (N.D. Cal. 2005).

Opinion

ORDER DENYING DEFENDANTS’ MOTION TO DISMISS

(Docket No. 8)

CHEN, United States Magistrate Judge.

Plaintiffs Afshin Adibi and International Pharmaceutical Services (“IPS”) have filed suit pursuant to 42 U.S.C. § 1983 against Defendants the California State Board of Pharmacy (“Board”) and its executive director Patricia Harris in her official capacity. Plaintiffs seek (1) a declaration that Defendants have violated the Dormant Commerce Clause by trying to revoke or suspend Plaintiffs’ pharmaceutical license and permit and (2) an injunction barring Defendants from revoking or suspending the same. Currently pending before the Court is Defendants’ motion to dismiss for failure to state a claim upon which relief can be granted and for lack of subject matter jurisdiction. Having considered the parties’ briefs and accompanying submissions, the Court hereby DENIES Defendants’ motion to dismiss.

I. FACTUAL & PROCEDURAL BACKGROUND

In their complaint, Plaintiffs allege the following facts.

The Board is the official body of the state that regulates licensed pharmacists and licensed wholesalers of pharmaceuticals in the State of California. See Compl. ¶ 4. Ms. Harris is the executive director of the Board. See id. Mr. Adibi has been licensed by the Board as a pharmacist since 1991. See id. ¶ 5. Since 1995, IPS has held a wholesaler permit issued by the Board. See id. Mr. Adibi is the sole owner, president, and operator of IPS. See id.

Beginning in 1995, Plaintiffs began to export pharmaceuticals to foreign countries. See id. ¶ 6. All of the shipments were made by IPS at the instance and direction of Mr. Adibi. See id. Subsequently, Defendants brought an administrative proceeding against Plaintiffs, seeking to revoke or suspend both Mr. Adibi’s license and IPS’s wholesaler permit based on Plaintiffs’ exportation of pharmaceuticals. See id. ¶ 7. After Defendants initiated the administrative proceeding against Plaintiffs, Plaintiffs filed the instant suit, claiming that Defendants’ attempt to revoke or suspend the license and permit was a violation of the Commerce Clause of the Constitution. See id. ¶ 9 (“Defendants’ assertion of disciplinary authority over [Pjlaintiffs’ license and permit, respectively, on the basis of [Pjlaintiffs’ conduct which took place entirely in foreign commerce violates that Constitution of the *1003 United States in that it constitutes an extraterritorial application of the laws of California and an attempt by [Defendants as agents of the State of California to regulate the conduct of foreign commerce.”); see also Opp’n at 1 (“Does the Commerce Clause, or perhaps what is called the Silent Commerce Clause, of the federal Constitution override the disciplinary authority of the State of California with respect to conduct which has occurred solely in the foreign commerce of the United States and which has no separate effects within that State?”).

Based on papers filed by Defendants, 1 it appears that Defendants sought to revoke or suspend Plaintiffs’ license and permit for various reasons, including but not limited to the following:

(1) Dispensing dangerous drugs at retail without being licensed as a pharmacy (as opposed to a wholesaler), a violation of California Business & Professions Code § 4110. See Cal. Bus. & Prof.Code § 4110(a) (“No person shall conduct a pharmacy in the State of California unless he or she has obtained a license from the board.”).

(2) Failing to obtain a DEA registration to dispense and export dangerous drugs, a violation of 21 C.F.R. § 1301.11(a), thereby violating California Business & Professions Code § 4059.5(e). See 21 C.F.R. § 1301.11(a) (“Every person who manufactures, distributes, dispenses, imports, or exports any controlled substance or who proposes to engage in the manufacture, distribution, dispensing, importation or exportation of any controlled substance shall obtain a registration unless exempted by law or pursuant to §§ 1301.22-1301.26.”); Cal. Bus. & Prof.Code § 4059.5(e) (“A dangerous drug or dangerous device shall not be transferred, sold, or delivered to a person outside this state, whether foreign or domestic, unless the transferor, seller, or deliverer does so in compliance with the laws of this state and of the United States and of the state or country to which the dangerous drugs or dangerous devices are to be transferred, sold, or delivered.”).

(3)Transferring, selling, or delivering dangerous drugs outside of the United States to persons unauthorized by local and international law to receive the drugs, a violation of California Business & Professions Code § 4059.5(e). For example, Plaintiffs allegedly exported dangerous drugs to a foreign country subject to a trade embargo by the United States without prior government approval.

II. DISCUSSION

A. Legal Standard

Pursuant to Federal Rule of Civil Procedure 12(b)(6), a defendant may move to dismiss for “failure to state a claim upon which relief can be granted.” Fed. R.Civ.P. 12(b)(6). In deciding whether to dismiss, a court may consider only the facts alleged in the complaint, documents attached as exhibits or incorporated by reference in the complaint, and matters of which the court may take judicial notice. See United States v. Ritchie, 342 F.3d 903, 908 (9th Cir.2003) (“A court may ... consider certain materials — documents attached to the complaint, documents incorporated by reference in the complaint, or matters of judicial notice — without converting the motion to dismiss into a motion *1004 for summary judgment.”)- The court must accept the plaintiffs allegations in the complaint as true and construe them in the light most favorable to the plaintiff. See Janas v. McCracken (In re Silicon Graphics Sec. Litig.), 183 F.3d 970, 983 (9th Cir.1999). Dismissal is improper “unless it appears beyond doubt that the plaintiff can prove no set of facts in support of his claim which would entitle him to relief.” Conley v. Gibson, 355 U.S. 41, 45-46, 78 S.Ct. 99, 2 L.Ed.2d 80 (1957).

Pursuant to Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sandhu v. Taylor
Ninth Circuit, 2025
Ramirez v. United Airlines, Inc.
416 F. Supp. 2d 792 (N.D. California, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
393 F. Supp. 2d 999, 2005 U.S. Dist. LEXIS 23657, 2005 WL 2491567, Counsel Stack Legal Research, https://law.counselstack.com/opinion/adibi-v-california-state-board-of-pharmacy-cand-2005.